LONDON - Shares in Phorm have leapt more than 50 per cent to 305p, following the announcement that it would roll out its controversial technology next year.
Phorm announced yesterday that it had completed a trial with BT that had successfully tested the technology.
Before the announcement, the company's share price was 200p, after which it rose to 305p today.
Phorm is behind technology that analyses web users' behaviour in a bid to serve up more relevant advertising.
The company has been criticised because of fears that its technology will allow internet companies to spy on users.
Join a growing community of media, marketing and advertising professionals today
Read exclusive registrant only articles
Read more articles each month
Sign up for free specialised news bulletins
Register NowGet unprecedented new-business intelligence with access to ±±¾©Èü³µpk10’s new Market Reports.
Find out moreGet unlimited access to ±±¾©Èü³µpk10’s premium content for your whole company with a corporate licence.
Upgrade accessGet the latest creative jobs in advertising, media, marketing and digital delivered directly to your inbox each day.
Create an alert now
.jpg)
.jpg)